Health Care & Life Sciences » Pharmaceuticals | Kalbe Farma

Kalbe Farma | Income Statement

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
16,002,131
17,368,533
17,887,464
19,374,231
20,182,120
21,074,306
Cost of Goods Sold (COGS) incl. D&A
8,475,469
9,084,308
9,513,271
10,115,722
10,651,076
11,509,825
Gross Income
7,526,662
8,284,224
8,374,193
9,258,509
9,531,044
9,564,481
SG&A Expense
4,945,438
5,484,173
5,676,696
6,119,581
6,261,155
6,167,527
EBIT
2,548,919
-
2,561,741
2,976,165
3,147,951
3,165,314
Non Operating Income/Expense
4,152
87,487
102,382
41,022
37,774
71,997
Interest Expense
28,642
52,009
23,918
28,149
36,392
29,738
Pretax Income
2,574,854
2,765,593
2,720,881
3,091,188
3,241,187
3,306,400
Income Tax
602,070
642,916
663,187
740,304
787,935
809,138
Equity in Affiliates
2,331
-
-
-
-
-
Consolidated Net Income
1,970,452
2,122,678
2,057,694
2,350,885
2,453,251
2,497,262
Net Income
1,919,508
2,066,022
2,004,237
2,299,735
2,403,606
2,457,129
Net Income After Extraordinaries
1,919,508
2,066,022
2,004,237
2,299,735
2,403,606
2,457,129
Net Income Available to Common
1,919,508
2,066,022
2,004,237
2,299,735
2,403,606
2,457,129
EPS (Basic)
41.00
44.08
42.76
49.06
51.28
52.42
Basic Shares Outstanding
46,875
46,875
46,875
46,875
46,875
46,875
EPS (Diluted)
40.95
44.08
42.76
49.06
51.28
52.42
Diluted Shares Outstanding
46,875
46,875
46,875
46,875
46,875
46,875
EBITDA
2,823,592
3,010,067
2,950,455
3,416,927
3,596,499
3,628,204
Other Operating Expense
32,305
130,667
135,756
162,762
121,938
231,640
Non-Operating Interest Income
50,425
63,368
81,581
106,259
108,159
101,500
Minority Interest Expense
50,944
56,656
53,457
51,150
49,645
40,133
Equity in Affiliates (Pretax)
-
2,637
905
4,109
16,306
2,674

About Kalbe Farma

View Profile
Address
Gedung KALBE
Jakarta JK 10510
Indonesia
Employees -
Website http://www.kalbe.co.id
Updated 07/08/2019
PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.